ADCT Annual Working Capital
$268.62 M
-$84.42 M-23.91%
31 December 2023
Summary:
As of January 23, 2025, ADCT annual working capital is $268.62 million, with the most recent change of -$84.42 million (-23.91%) on December 31, 2023. During the last 3 years, it has fallen by -$141.39 million (-34.48%). ADCT annual working capital is now -40.47% below its all-time high of $451.25 million, reached on December 31, 2021.ADCT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADCT Quarterly Working Capital
$265.33 M
-$32.40 M-10.88%
30 September 2024
Summary:
As of January 23, 2025, ADCT quarterly working capital is $265.33 million, with the most recent change of -$32.40 million (-10.88%) on September 30, 2024. Over the past year, it has dropped by -$3.29 million (-1.23%). ADCT quarterly working capital is now -47.88% below its all-time high of $509.11 million, reached on September 30, 2021.ADCT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADCT Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.9% | -1.2% |
| 3 y3 years | -34.5% | -41.2% |
| 5 y5 years | +124.4% | -41.2% |
ADCT Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.5% | at low | -41.2% | +16.8% |
| 5 y | 5-year | -40.5% | +161.7% | -47.9% | +158.4% |
| alltime | all time | -40.5% | +161.7% | -47.9% | +158.4% |
ADC Therapeutics SA Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $265.33 M(-10.9%) |
| June 2024 | - | $297.73 M(+31.0%) |
| Mar 2024 | - | $227.22 M(-15.4%) |
| Dec 2023 | $268.62 M(-23.9%) | $268.62 M(-9.7%) |
| Sept 2023 | - | $297.39 M(-10.5%) |
| June 2023 | - | $332.23 M(+11.1%) |
| Mar 2023 | - | $298.92 M(-15.3%) |
| Dec 2022 | $353.04 M(-21.8%) | $353.04 M(+0.7%) |
| Sept 2022 | - | $350.53 M(-0.1%) |
| June 2022 | - | $350.76 M(-15.9%) |
| Mar 2022 | - | $416.94 M(-7.6%) |
| Dec 2021 | $451.25 M | $451.25 M(-11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $509.11 M(+48.5%) |
| June 2021 | - | $342.93 M(-2.5%) |
| Mar 2021 | - | $351.84 M(-14.2%) |
| Dec 2020 | $410.01 M(+299.4%) | $410.01 M(-13.5%) |
| Sept 2020 | - | $473.86 M(+44.6%) |
| June 2020 | - | $327.76 M(+219.3%) |
| Dec 2019 | $102.66 M(-14.3%) | - |
| Dec 2019 | - | $102.66 M(-39.0%) |
| June 2019 | - | $168.39 M(+40.6%) |
| Dec 2018 | $119.73 M(-51.1%) | - |
| Dec 2018 | - | $119.73 M |
| Dec 2017 | $244.63 M(+72.8%) | - |
| Dec 2016 | $141.59 M | - |
FAQ
- What is ADC Therapeutics SA annual working capital?
- What is the all time high annual working capital for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual working capital year-on-year change?
- What is ADC Therapeutics SA quarterly working capital?
- What is the all time high quarterly working capital for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly working capital year-on-year change?
What is ADC Therapeutics SA annual working capital?
The current annual working capital of ADCT is $268.62 M
What is the all time high annual working capital for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual working capital is $451.25 M
What is ADC Therapeutics SA annual working capital year-on-year change?
Over the past year, ADCT annual working capital has changed by -$84.42 M (-23.91%)
What is ADC Therapeutics SA quarterly working capital?
The current quarterly working capital of ADCT is $265.33 M
What is the all time high quarterly working capital for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly working capital is $509.11 M
What is ADC Therapeutics SA quarterly working capital year-on-year change?
Over the past year, ADCT quarterly working capital has changed by -$3.29 M (-1.23%)